Luo et al. constructed a ceRNA network of AGAP2-AS1-miR-9-5p-MMP-2/MMP-9 and identified that AGAP2-AS1 was a promising therapeutic target for GBM [27]. The gene discussed is AGAP2; the disease is glioblastoma.